Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Deep Brain Stimulation (DBS) Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Single-Channel Systems, Dual-Channel Systems, Implantable Pulse Generators , Leads and Electrodes, Extensions and Accessories), By Technology (Rechargeable DBS Systems, Non-rechargeable DBS Systems, Sensing-Enabled), By Application (Parkinson’s Disease, Essential Tremor, Dystonia, Epilepsy, Obsessive-Compulsive Disorder , Depression and Chronic Pain), By End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers , Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Deep Brain Stimulation (DBS) Devices Market size is forecast to increase from $1.91 Billion in 2026 to $4.25 Billion in 2034 at a CAGR of 10.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006657
Pages: 213 Pages

D-dimer Testing Market Size, Share and Growth Outlook, 2026: Analysis By Product Category (Reagents and Assay Kits, Automated Analyzers, Consumables and Accessories), By Sample Matrix Type (Plasma Samples, Whole Blood Samples), By Testing Location Format (Laboratory-Based Testing Platforms, Point-of-Care Testing ), By Core Clinical Application (Deep Vein Thrombosis , Pulmonary Embolism , Disseminated Intravascular Coagulation , Venous Thromboembolism ), By End-User (Hospital Laboratories, Independent Diagnostic Laboratories, Ambulatory Surgical Centers , Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global D-dimer Testing Market size is forecast to increase from $2.2 Billion in 2026 to $3.2 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006656
Pages: 210 Pages

Data Monetization Solutions For Life Science Companies Market Size, Share and Growth Outlook, 2026: Analysis By Monetization Method Type (Direct Data Monetization , Indirect Data Monetization ), By Solution Component (Software Platforms, Professional and Managed Services), By Deployment Mode (Cloud-Based , On-Premises), By Enterprise (Large Life Science Facilities, Small & Medium Life Science Facilities), By Application Area (Drug Discovery and R&D, Clinical Trial Optimization, Precision , Commercial and Real-World Evidence) Companies, and Country Forecast, 2021 to 2034

Global Data Monetization Solutions For Life Science Companies Market size is forecast to increase from $466.19 Million in 2026 to $1497.03 Million in 2034 at a CAGR of 15.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006655
Pages: 224 Pages

Data Monetization Solutions For Healthcare Payers Market Size, Share and Growth Outlook, 2026: Analysis By Type (Direct Data Monetization Software, Indirect Data Monetization Software, Managed Services), By Deployment Mode (Cloud-based, On-premise), By Facility Size (Large Healthcare Payers, Small & Medium Healthcare Payers), By Application (Claims Management and Fraud Detection, Risk Assessment and Underwriting, Population Health Management, Member Engagement and Retention, Value-Based Care Modeling), By End User (Public Payers , Private Payers , Third-Party Administrators) Companies, and Country Forecast, 2021 to 2034

Global Data Monetization Solutions For Healthcare Payers Market size is forecast to increase from $478.87 Million in 2026 to $1495.73 Million in 2034 at a CAGR of 15.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006654
Pages: 227 Pages

Data Monetization Solution For Healthcare Providers Market Size, Share and Growth Outlook, 2026: Analysis By Type (Data Monetization Software, Data Monetization Services), By Monetization Model (Direct Data Monetization , Indirect Data Monetization ), By Deployment Mode (Cloud-based, On-premise), By Application (Clinical Data Analysis, Patient Engagement and Personalization, Operational Efficiency and Supply Chain Optimization, Drug Discovery and Development Support), By End User (Hospitals and Clinics, Diagnostic and Imaging Centers, Academic and Research Medical Centers) Companies, and Country Forecast, 2021 to 2034

Global Data Monetization Solution For Healthcare Providers Market size is forecast to increase from $180.41 Million in 2026 to $599.67 Million in 2034 at a CAGR of 16.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006653
Pages: 222 Pages

Dasatinib Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Branded , Generic), By Indication (Chronic Myeloid Leukemia , Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia ), By Dosage Form (Tablets, Oral Suspension), By End User (Hospitals, Specialty Cancer Centers, Home Healthcare Settings) Companies, and Country Forecast, 2021 to 2034

Global Dasatinib Market size is forecast to increase from $1.27 Billion in 2026 to $1.66 Billion in 2034 at a CAGR of 3.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006652
Pages: 227 Pages

Darier Disease Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Topical Retinoids, Oral Retinoids, Corticosteroids and Anti-inflammatory Agents, Antibacterial & Antiviral Prophylactics, Biologics and Targeted Immunotherapies), By Route of Administration (Topical Formulations , Oral Formulations , Injectable ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online Pharmacies ), By End-User Environment (Specialized Dermatology Clinics, General Hospitals and Tertiary Care Facilities, Homecare and Outpatient Settings) Companies, and Country Forecast, 2021 to 2034

Global Darier Disease Drugs Market size is forecast to increase from $238.27 Million in 2026 to $333.69 Million in 2034 at a CAGR of 4.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006651
Pages: 214 Pages

Dairy Herd Management Market Size, Share and Growth Outlook, 2026: Analysis By Product Category (Hardware , Management Software , Managed Services ), By Operational Application (Milk Harvesting and Yield Management, Feeding & Nutrition Management, Breeding, Reproductive Management, and Genomic Selection, Health, Mastitis, and Disease Management), By Farm Classification (Conventional Dairy Farms, Organic Dairy Farms, Robotic ), By Enterprise (Large-Scale Dairy Farms, Medium-Scale Dairy Farms, Small-Scale Dairy Farms) Companies, and Country Forecast, 2021 to 2034

Global Dairy Herd Management Market size is forecast to increase from $5.36 Billion in 2026 to $11.16 Billion in 2034 at a CAGR of 9.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006650
Pages: 226 Pages

Dacryocystitis Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Indication Type (Acute Dacryocystitis, Chronic Dacryocystitis, Congenital Dacryocystitis), By Treatment Modality (Medication , Surgical Procedures , Conservative ), By Distribution Channel (Institutional Sales , Retail Sales , Online ), By End-User Facility (General Hospitals and Medical Centers, Ophthalmology Clinics & Specialized Eye Care Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Dacryocystitis Treatment Market size is forecast to increase from $364.27 Million in 2026 to $571.89 Million in 2034 at a CAGR of 5.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006649
Pages: 216 Pages

Cytotoxic Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Alkylating Agents, Antimetabolites, Antitumor Antibiotics , Plant Alkaloids , Topoisomerase Inhibitors, Platinum-based Drugs), By Drug Type (Branded Drugs, Generic Drugs), By Route of Administration (Parenteral , Oral), By Application (Oncology , Rheumatoid Arthritis, Multiple Sclerosis, Other Autoimmune Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online Pharmacies, Cancer Treatment Centers) Companies, and Country Forecast, 2021 to 2034

Global Cytotoxic Drugs Market size is forecast to increase from $17.83 Billion in 2026 to $27.57 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006648
Pages: 220 Pages